BASF, DE000BASF111

BASF confirms Evonik talks. BASF stock sits 9.61 percent below its high

Published on 10/01/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 16.00 percent to EUR 17.20 billion. BASF stock costs EUR 49.76 on October 1, 2026 versus prior EUR 50.02.

Luftaufnahme eines Chemiewerks bei Nacht mit leuchtendem Rohrnetz, Destillationskolonnen und Fackeln
Cinematische Drohnenaufnahme eines weitläufigen Petrochemie-Komplexes bei Nacht aus ca. 300 Metern Höhe. Hunderte beleuchteter Rohrleitungen, Destillationskolonnen und Reaktortürme bilden ein leuchtendes Gitternetz. Bernsteinfarbene, weiß-blaue Industrielichter spiegeln sich auf dem Boden und in Dampfwolken. Anamorphe Linsenoptik, kinematisches Teal-Shadow-Grading, Illustration mit AI erstellt.

BASF stock (ISIN DE000BASF111) was at EUR 49.76 at Lang & Schwarz on October 1, 2026 at 3:00 p.m. CEST, down 0.52 percent from the prior close of EUR 50.02. On September 25, 2026, BASF confirmed exploratory talks with RAG-Stiftung and Evonik regarding a potential takeover, while stating that the course and outcome remained open.

Evonik talks raise the strategic stakes

The announcement puts capital allocation beside BASF's operating recovery. The company said its acquisition strategy targets stronger core businesses, strategic fit, profitable growth and value creation, but gave no transaction terms in the September 25 release.

That uncertainty matters because a large acquisition could compete with shareholder distributions and ongoing portfolio investments. BASF's own release described the discussions as exploratory rather than a completed transaction, keeping the headline event tied to negotiations rather than a signed deal.

Second-quarter revenue rose 16.00 percent

According to Stock-World on September 5, 2026, BASF reported second-quarter 2026 revenue of EUR 17.20 billion, up 16.00 percent from the prior-year period. The same report said adjusted EBITDA before special items reached EUR 2.40 billion and that BASF raised its full-year 2026 adjusted EBITDA guidance to EUR 6.90 billion to EUR 7.70 billion.

The operating comparison is significant for the takeover debate: the second-quarter improvement came with price growth of 11.50 percent and volume growth of 7.30 percent, according to the same report. Those figures provide an operating benchmark as investors weigh a potentially larger strategic commitment.

Analysts split over BASF valuation

Analyst views also show a wide range. finanzen.ch reported on September 30, 2026 that three of four analysts reviewing BASF in September rated the stock a buy, while one rated it a sell, with an average target of EUR 56.00.

MarketScreener reported on September 22, 2026 that Bernstein Research raised its target from EUR 62.00 to EUR 63.00 and kept an Outperform rating. That target is 26.53 percent above the Lang & Schwarz price, using the same euro currency.

Stock stays below its yearly high

At EUR 49.76, BASF was 9.61 percent below its 52-week high of EUR 55.05 and EUR 8.28 above its 52-week low of EUR 41.48 on October 1, 2026. The stock therefore sits in the upper half of its annual range, while the daily move remains below the 1.00 percent threshold for a directional market signal.

The further course of trading is shown by the continuously updated real-time quote of BASF stock.

BASF stock facts

  • Company: BASF SE
  • ISIN: DE000BASF111
  • WKN: BASF11
  • Ticker: BAS
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of October 1, 2026, 3:00 p.m. CEST): EUR 49.76
  • Change versus prior close: minus 0.52 percent
  • Prior close Lang & Schwarz (September 30, 2026): EUR 50.02
  • Market capitalization: EUR 43.0 billion (as of October 1, 2026)
  • 52-week range: EUR 41.48-EUR 55.05 (as of October 1, 2026)
  • Sector / Industry: Chemicals / Diversified Chemicals
  • Index membership: DAX
  • Next earnings date: October 28, 2026

More news and analyses on BASF stock

Disclaimer...

en | DE000BASF111 | BASF | boerse | 70210761 | bgmi